EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Immunomodulatory Effect of Different FLT3 Inhibitors on Dendritic Cells

Sebastian Schlaweck iD, Alea Radcke iD, Sascha Kampmann, Benjamin V Becker iD, Peter Brossart, Annkristin Heine

Cancers · 04.11.2024 · 16 (21) · 3719

DOI: 10.3390/cancers16213719 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 04.11.2024. Verfasst von Sebastian Schlaweck und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Clinic III for Hematology, Oncology, Rheumatology, Immunoncology and Stem-Cell Transplantation, University of Bonn, 53127 Bonn, Germany. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Cancer Aid, Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

FMS-like tyrosine kinase 3 (FLT3) mutations or internal tandem duplication occur in 30% of acute myeloid leukemia (AML) cases. In these cases, FLT3 inhibitors (FLT3i) are approved for induction treatment and relapse. Allogeneic hematopoietic stem cell transplantation (alloHSCT) remains the recommended post-induction therapy for suitable patients. However, the role of FLT3i therapy after alloHSCT remains unclear. Therefore, we investigated the three currently available FLT3i, gilteritinib, midostaurin, and quizartinib, in terms of their immunosuppressive effect on dendritic cells (DCs). DCs are professional antigen-presenting cells inducing T-cell responses to infectious stimuli. Highly activated DCs can also cause complications after alloHSCT, such as triggering Graft versus Host disease, a serious and potentially life-threatening complication after alloHSCT.

Methods

To study the immunomodulatory effects on DCs, we differentiated murine and human DCs in the presence of FLT3i and performed immunophenotyping by flow cytometry and cytokine measurements and investigated gene and protein expression.

Results

We detected a dose-dependent immunosuppressive effect of midostaurin, which decreased the expression of costimulatory markers like CD86, and found a reduced secretion of pro-inflammatory cytokines such as IL-12, TNFα, and IL-6. Mechanistically, we show that midostaurin inhibits TLR and TNF signaling and NFκB, PI3K, and MAPK pathways. The immunosuppressive effect of gilteritinib was less pronounced, while quizartinib did not show truncation of relevant signaling pathways.

Conclusions

Our results suggest different immunosuppressive effects of these three FLT3i and may, therefore, provide an additional rationale for optimal maintenance therapy after alloHSCT of FLT3-positive AML patients to prevent infectious complications and GvHD mediated by DCs.

Schlagwörter

Stichwörter der Autor:innen

AMLFLT3dendritic cellsgilteritinibmidostaurinquizartinib

Autor:innen und Institutionen

  • Medical Clinic III for Hematology, Oncology, Rheumatology, Immunoncology and Stem-Cell Transplantation, University of Bonn, 53127 Bonn, Germany.
  • Faculty of Medicine, Mildred Scheel School of Oncology Aachen Bonn Cologne Düsseldorf (MSSO ABCD), University Hospital of Bonn, 53127 Bonn, Germany.
  • Department of Radiology and Neuroradiology, Bundeswehr Central Hospital, 56072 Koblenz, Germany.

ORCID-Profile: Sebastian Schlaweck, Alea Radcke, Benjamin V Becker

Förderung

  • German Cancer Aid
  • Deutsche Forschungsgemeinschaft
  • Deutsche Krebshilfe

Zitieren

APA

Schlaweck, S., Radcke, A., Kampmann, S., Becker, B. V., Brossart, P., & Heine, A. (2024). The Immunomodulatory Effect of Different FLT3 Inhibitors on Dendritic Cells. Cancers, 16(21), 3719. https://doi.org/10.3390/cancers16213719

Vancouver

Schlaweck S, Radcke A, Kampmann S, Becker BV, Brossart P, Heine A. The Immunomodulatory Effect of Different FLT3 Inhibitors on Dendritic Cells. Cancers. 2024;16(21):3719. doi:10.3390/cancers16213719

BibTeX
@article{Schlaweck2024,
  author = {Schlaweck, Sebastian and Radcke, Alea and Kampmann, Sascha and Becker, Benjamin V and Brossart, Peter and Heine, Annkristin},
  title = {The Immunomodulatory Effect of Different FLT3 Inhibitors on Dendritic Cells},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {21},
  pages = {3719},
  doi = {10.3390/cancers16213719}
}
Kostenlos starten →